EBERS has been recently awarded with a Eurostars R&D project focused on the development of a stem cell technology for scalable, sustainable, and animal-friendly lab-grown meat. The project will involve the cooperation of four EU SMEs: Meatable, Elpis, HCS and EBERS. EBERS will be involved in the design and development of a bioreactor for cell maturation.
EBERS participated last July 9 in a seminar held in Beijing by our distributor in China, Cy-Tech. Our CEO, Pedro Moreo, talked about the advantages of normothermic perfusion applied to organs for transplantation and introduced the last results obtained with EBERS’ technology in animal models. Around one hundred people assisted to the meeting.
The normothermic preservation technology from EBERS was presented during the TERMIS-EU conference that took place on May 26-31 in Rhodes, Greece. The company was present with a stand in the commercial exhibition of the conference and, in addition, EBERS’ CEO presented participated with two posters in the scientific sessions of the conference.
EBERS participated in the commercial exhibition of the European Society for Organ Transplantation (ESOT) congress that took place on September 15-18 in Copenhagen. The company showcased two units of the new normothermic organ preservation device in a stand and in a specific area of the venue exclusively dedicated to organ preservation technology. In addition, scientific results obtained with the system were presented in the scientific sessions.